Van Andel Research Institute Adopts Aushon Arrayer for Cancer Studies

Grand Rapids, Mich.-based VARI will use the arrayer as part of an effort to identify and study protein abnormalities in the blood of cancer patients, with the ultimate goal of developing blood tests for the early detection or more accurate diagnosis of cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.